Table 2.
Demographics and clinical characteristics of chemotherapy-induced anemia patients for selected cancers: Aarhus and North Jutland, Denmark (1998–2003)
| All cancers | Hematologic | Solid tumors (all) | Lung | Colorectal | Breast | Gynecologic | Urinary tract | Gastrointestinal | Prostate | Othera | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number and proportion of patients, n (%) | 1782 (100) | 590 (33) | 1192 (67) | 324 (18) | 256 (14) | 214 (12) | 204 (11) | 50 (3) | 44 (2) | 5 (0.3) | 95 (5) |
| Median age (years) | 58 | 57 | 59 | 62 | 63 | 51 | 58 | 57 | 64 | 61 | 36 |
| Minimum, maximum | (0.1, 90) | (0.4, 90) | (0.1, 88) | (31, 81) | (24, 85) | (28, 82) | (1, 86) | (1, 84) | (24, 88) | (54, 73) | (0.1, 86) |
| Male sex, n (%) | 754 (42) | 334 (57) | 420 (35) | 183 (56) | 127 (50) | 1 (0.5) | 0 (0) | 25 (50) | 24 (54) | 5 (100) | 55 (58) |
| Female sex, n (%) | 1028 (58) | 256 (43) | 772 (65) | 141 (44) | 129 (50) | 213 (99.5) | 204 (100) | 25 (50) | 20 (46) | 0 (0) | 40 (42) |
| Treatment, n (%) | |||||||||||
| Chemotherapy | 1048 (59) | 568 (96) | 480 (40) | 301(93) | 21 (8) | 32 (15) | 23 (11) | 24 (48) | 37 (84) | 4 (80) | 38 (40) |
| Chemotherapy and surgery | 734 (41) | 22 (4) | 712 (60) | 23 (7) | 235 (92) | 182 (85) | 181 (89) | 26 (52) | 7 (16) | 1 (20) | 57 (60) |
| Cancer stage, n (%) | |||||||||||
| I | 20 (1) | 0 (0) | 20 (2) | 0 (0) | 0 (0) | 0 (0) | 20 (10) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| II | 215 (12) | 50 (8) | 165 (14) | 23 (7) | 4 (2) | 79 (37) | 15 (7) | 11 (22) | 3 (7) | 0 (0) | 30 (32) |
| III | 562 (32) | 51 (9) | 511 (43) | 121 (37) | 135 (53) | 98 (46) | 108 (53) | 10 (20) | 14 (32) | 2 (40) | 23 (24) |
| IV | 618 (35) | 163 (28) | 455 (38) | 170 (52) | 114 (44) | 29 (14) | 58 (28) | 23 (46) | 23 (52) | 2 (40) | 36 (38) |
| Unknown | 367 (21) | 326 (55) | 41 (3) | 10 (3) | 3 (1) | 8 (4) | 3 (2) | 6 (12) | 4 (9) | 1 (20) | 6 (6) |
Note:
a
Includes endocrinal glands, bone, melanoma of skin, connective tissue, other and unspecified male genital organs, testis, eye, brain and nervous system, thyroid, metastases, nonmelanoma of skin, and peritoneum and unspecified connective tissue.